Analysis of the Medication Persistence Rate for and Adherence to Oral 5-Aminosalicylic Acid Preparations in Japanese Patients with Ulcerative Colitis: Study Using a Nationwide Claims Database
Digestion · 2024
DOI: 10.1159/000538319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestion, 2024. Verfasst von Takumi Ota und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Affairs Department, Mochida Pharmaceutical Co., Ltd., Tokyo, Japan. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Mesalamine, Anti-Inflammatory Agents, Non-Steroidal, Databases, Factual. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
5-aminosalicylic acid (5-ASA) is the first-line drug for the treatment of mild-to-moderate ulcerative colitis (UC). Three oral sustained-release formulations are often used. However, no unified view of their actual use in routine medical practice has been presented to date.
Methods
Using a health insurance claims database, we extracted patients with an initial diagnosis of mild-to-moderate UC during the period from December 1, 2017, to March 31, 2022. For the three types of oral 5-ASA formulation, we calculated and compared descriptive statistics of medication persistence rates (MPR), proportions of days covered (PDC), and adherence proportion (PDC ≥80%) in the extracted population.
Results
An oral 5-ASA formulation was used in combination with a topical preparation (cohort 1) in 899 patients, and oral 5-ASA was used alone (cohort 2) in 1,829 patients. In cohort 1, MPR at days 151–180 with concomitant use of topical formulation was significantly higher for the Multi Matrix System™ (MMX) formulation (65.2%) compared with that for pH-dependent formulation (51.7%, p < 0.025), while MPR tended to be higher for MMX than for the time-dependent formulation (56.4%, not significant). During days 151–180 after starting the oral formulation, MPR for MMX (66.7% and 65.8%) was higher than for pH-dependent (55.9% and 55.3%) and time-dependent (57.6% and 55.9%) formulations in cohorts 1 + 2 and 2, respectively. In cohort 1, there was a significant difference between MMX (68.3%) and pH-dependent (57.1%) formulations, but no significant difference was seen with time-dependent formulations (61.8%). In terms of the proportion of adherence until day 180, MMX was significantly better than the other formulations.
Conclusion
The analyses of the three oral 5-ASA formulations suggested that both MPR and medication adherence were better for the MMX formulation than for time-dependent or pH-dependent formulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Affairs Department, Mochida Pharmaceutical Co., Ltd., Tokyo, Japan.
- Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan.
Zitieren
APA
Ota, T., Takebe, T., Shimizu, Y., Orido, T., Tanaka, H., & Nakamura, S. (2024). Analysis of the Medication Persistence Rate for and Adherence to Oral 5-Aminosalicylic Acid Preparations in Japanese Patients with Ulcerative Colitis: Study Using a Nationwide Claims Database. Digestion. https://doi.org/10.1159/000538319
Vancouver
Ota T, Takebe T, Shimizu Y, Orido T, Tanaka H, Nakamura S. Analysis of the Medication Persistence Rate for and Adherence to Oral 5-Aminosalicylic Acid Preparations in Japanese Patients with Ulcerative Colitis: Study Using a Nationwide Claims Database. Digestion. 2024. doi:10.1159/000538319
BibTeX
@article{Ota2024,
author = {Ota, Takumi and Takebe, Takahiro and Shimizu, Yutaka and Orido, Takashi and Tanaka, Hiroyuki and Nakamura, Shiro},
title = {Analysis of the Medication Persistence Rate for and Adherence to Oral 5-Aminosalicylic Acid Preparations in Japanese Patients with Ulcerative Colitis: Study Using a Nationwide Claims Database},
journal = {Digestion},
year = {2024},
doi = {10.1159/000538319}
}
EUVIMED